EXPERIENCE OF USING THE DRUG GEPON IN THE TREATMENT OF PATIENTS FOCAL SCLERODERMA

Authors

  • Narzikulov R. M. Samarkand State Medical Institute

Keywords:

Localized scleroderma, combined treatment, gepon

Abstract

We conducted a study of the effectiveness of the drug gepon in focal (localized) scleroderma. The main study group consisted of 19 patients with focal scleroderma aged 22 to 45 years. Among the patients, 11 men and 8 women. The duration of the disease varied from 3 to 10 years. Skin lesions were limited in nature, more often localized mainly on the face, chest, abdomen and lower leg. In addition to Gepon, patients were treated with traditional methods of treatment. We have obtained the following conclusions: the inclusion of the drug Gepon in the complex treatment of focal (localized) scleroderma contributes to a faster resolution of the pathological process and the restoration of skin elasticity.

Downloads

Published

2021-03-11

Issue

Vol. 8 No. 3 (2021): IJIERT

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0 DEED).

You are free to:

  1. Share — copy and redistribute the material in any medium or format
  2. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. NonCommercial — You may not use the material for commercial purposes .
  3. NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  4. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

 

Rights of Authors

Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.

How to Cite

Narzikulov R. M. (2021). EXPERIENCE OF USING THE DRUG GEPON IN THE TREATMENT OF PATIENTS FOCAL SCLERODERMA. International Journal of Innovations in Engineering Research and Technology, 8(3), 5-6. https://repo.ijiert.org/index.php/ijiert/article/view/2292